• Doctor
  • Independent doctor

skindocUK Headquarters

Overall: Good read more about inspection ratings

100 Brighton Road, London, N16 8EG

Provided and run by:
skindocUK Ltd

All Inspections

6 July 2023

During a monthly review of our data

We carried out a review of the data available to us about skindocUK Headquarters on 6 July 2023. We have not found evidence that we need to carry out an inspection or reassess our rating at this stage.

This could change at any time if we receive new information. We will continue to monitor data about this service.

If you have concerns about skindocUK Headquarters, you can give feedback on this service.

26 July 2022

During a routine inspection

This service is rated as Good overall.

The key questions are rated as:

Are services safe? – Good

Are services effective? – Good

Are services caring? – Good

Are services responsive? – Good

Are services well-led? – Good

We carried out an announced comprehensive inspection at skindocUK Ltd as part of our inspection programme. This was the location’s first inspection since it registered with CQC.

SkindocUK Ltd is an online dermatology consultation service.

The provider is a partnership. One of the partners is the registered manager. A registered manager is a person who is registered with the Care Quality Commission to manage the service. Like registered providers, they are ‘registered persons’. Registered persons have legal responsibility for meeting the requirements in the Health and Social Care Act 2008 and associated Regulations about how the service is run.

Our key findings were:

  • The practice provided care in a way that kept patients safe and protected them from avoidable harm.
  • Patients received effective care and treatment that met their needs.
  • Staff dealt with patients with kindness and respect and involved them in decisions about their care.
  • Patients could access care and treatment in a timely way.
  • The way the practice was led and managed promoted the delivery of high-quality, person-centred care.

Whilst we found no breaches of the regulations, the provider should:

  • Implement a documented risk assessment process for the prescribing of Roaccutane (a prescription only medicine primarily used to treat severe acne), where the patient has declined for their GP to be notified.

Dr Sean O’Kelly BSc MB ChB MSc DCH FRCA

Chief Inspector of Hospitals and Interim Chief Inspector of Primary Medical Services